Recursion to Present at 43rd Annual JP Morgan Healthcare Conference
Recursion to Present at 43rd Annual JP Morgan Healthcare Conference
Salt Lake City, UT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announces that co-founder and CEO Chris Gibson, PhD will present at the upcoming 43rd Annual JP Morgan Healthcare Conference in San Francisco.
2025年1月6日，鹽湖城，猶他州（全球新聞社）—— Recursion Pharmaceuticals（納斯達克：RXRX），一家領先的臨牀階段科技生物公司，致力於解碼生物學以徹底改善生活，今天宣佈聯合創始人兼首席執行官克里斯·吉布森博士將在即將舉行的第43屆摩根大通醫療會議上發表演講，該會議將在舊金山舉行。
On Monday, January 13, 7:30am PT (10:30am ET), at the Westin St. Francis in the Elizabethan Room A/B, Dr. Gibson will present updates on Recursion's latest clinical pipeline, partnerships, and platform following the company's recent combination with Exscientia. The talk will be available on Recursion's website for at least 30 days following the presentation here: .
在1月13日星期一，太平洋時間7:30（東部時間10:30），在威斯汀聖弗朗西斯酒店的伊麗莎白時代A/b廳，吉布森博士將介紹Recursion最新的臨牀管線、合作伙伴關係及平台的更新，這些內容屬於公司最近與Exscientia的結合。演講將在Recursion的網站上提供，至少在演講後保持30天，請在此處查看。
CONTACT: Ryan Kelly
Recursion Pharmaceuticals
media@recursion.com
聯繫人：瑞安·凱利
Recursion Pharmaceuticals
media@recursion.com
譯文內容由第三人軟體翻譯。
